CD4 and Cryptococcal meningitis: In low-resource settings where antiretroviral therapy is not universally available and the burden of cryptococcal meningitis is very high, the WHO has recommended primary fluconazole prophylaxis for all HIV patients with a CD4 count < 100 cells/μL as this has been demonstrated to improve survival [20].